The results of Moneta Money bank $MONET.PR exceeded expectations on virtually all fronts. We asked the company's CFO, Jan Frick, for a more in-depth commentary on today's results.
📆 Key events of the week: What to watch out for? The new week will bring important macro data and company results that can influence the markets. We will also see the market reaction to Donald Trump's introduction of tariffs. Here is a summary of the key events:
Monday: 📊 ISM Manufacturing PMI - An important indicator of activity in the industry. Weaker numbers may fuel... Read more
I've had $Vstock on my watchlist for a long time , but the price has never seemed good enough to buy. The stock is up 8% just since the beginning of the year. I think Visa is a great company with a great business, but its stock is definitely not cheap.
💊 AbbVie beats expectations: shares rise thanks to strong results and optimistic outlook! 🚀
Shares of biotech giant AbbVie $ABBV are up more than 4 %, after announcing better-than-expected quarterly earnings while raising its long-term outlook. Sales of Skyrizi and Rinvoq were a key driver of growth , offsetting declines in the once-flagship drug Humira.
The results of Moneta Money bank $MONET.PR exceeded expectations on virtually all fronts. We asked the company's CFO, Jan Frick, for a more in-depth commentary on today's results.
https://www.youtube.com/watch?v=XQr2qbgXCLk3 new aristocrats among dividend stocks
📆 Key events of the week: What to watch out for?
The new week will bring important macro data and company results that can influence the markets. We will also see the market reaction to Donald Trump's introduction of tariffs. Here is a summary of the key events:
Monday:
📊 ISM Manufacturing PMI - An important indicator of activity in the industry. Weaker numbers may fuel...
Read more
Zobrazit další komentáře
There's a lot of results this week, but I'm more interested in how stocks will react to Trump's tariffs.
I've had $Vstock on my watchlist for a long time , but the price has never seemed good enough to buy. The stock is up 8% just since the beginning of the year. I think Visa is a great company with a great business, but its stock is definitely not cheap.
Does anyone have $Vstock in their portfolio ?
Zobrazit další komentáře
Great company to invest in for the long term, but I don't have the stock in my portfolio.
💊 AbbVie beats expectations: shares rise thanks to strong results and optimistic outlook! 🚀
Shares of biotech giant AbbVie $ABBV are up more than 4 %, after announcing better-than-expected quarterly earnings while raising its long-term outlook. Sales of Skyrizi and Rinvoq were a key driver of growth , offsetting declines in the once-flagship drug Humira.
...Read more
Zobrazit další komentáře
I don't like these stocks very much. The only stock I have from this sector is $NVO.